ObsEva SA, SWISS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch OBSEF and buy or sell other stocks, ETFs, and their options commission-free!

About OBSEF

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. 

CEO
Fabien de Ladonchamps
CEOFabien de Ladonchamps
Employees
15
Employees15
Headquarters
Geneva, Geneve (Geneva)
HeadquartersGeneva, Geneve (Geneva)
Founded
2012
Founded2012
Employees
15
Employees15

OBSEF Key Statistics

Market cap
11.72K
Market cap11.72K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
8.44K
Average volume8.44K
High today
$0.0001
High today$0.0001
Low today
$0.0001
Low today$0.0001
Open price
$0.0001
Open price$0.0001
Volume
4.00K
Volume4.00K
52 Week high
$0.0501
52 Week high$0.0501
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

With a market cap of 11.72K, ObsEva SA, SWISS(OBSEF) trades at $0.00.

On 2026-05-19, ObsEva SA, SWISS(OBSEF) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 4K, compared to an average daily volume of 8.44K.

The stock's 52-week range extends from a low of $0.00 to a high of $0.05.

The stock's 52-week range extends from a low of $0.00 to a high of $0.05.

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.